ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Octozi, a New York City-based AI company automating clinical development workflows for pharmaceutical sponsors, raised $3 million in seed funding. Surface Ventures led the round, with participation from Remarkable Ventures. The company will use the capital to further develop its platform, which integrates with existing clinical systems to automate data cleaning, reconciliation, review, and reporting.
Tracked by ByteBrief